LOGO.png
Autolus Therapeutics announces retirement of chief financial officer and succession plan
January 10, 2022 07:01 ET | Autolus Therapeutics plc
- Andrew J. Oakley to retire in March 2022 - Dr. Lucinda Crabtree to succeed him as chief financial officer LONDON, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Autolus Therapeutics plcĀ (Nasdaq: AUTL), a...
Autolus Therapeutics to Participate in Upcoming Investor Conferences in September
August 28, 2019 16:05 ET | Autolus Therapeutics plc
LONDON, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...
Autolus Therapeutics Reports Second Quarter 2019 Financial Results and Operational Progress
August 08, 2019 07:49 ET | Autolus Therapeutics plc
LONDON, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plcĀ (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...